Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02341235
Other study ID # 14-0376
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 2015
Est. completion date June 30, 2021

Study information

Verified date August 2021
Source The University of Texas Medical Branch, Galveston
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to compare an enhanced intervention that includes narrative and game components to a standard intervention that only targets self-monitoring. These approaches will be tested among postmenopausal breast cancer survivors who are sedentary and overweight.


Description:

Habitual physical activity decreases risk of multiple negative health outcomes, including breast cancer recurrence and mortality. It is also associated with better quality of life and reducing negative effects of cancer and cancer treatment. However, most breast cancer survivors do not engage in sufficient physical activity. Behavior change interventions produce short-term increases in activity but have difficulty motivating sustained active lifestyles over longer periods and are not equally effective in women of different races/ethnicities. The purpose of this study is to test a novel intervention that uses video games and storytelling to increase motivation. Video game mechanics increase enjoyment and feelings of autonomy (control), competence, and relatedness to others. All of these feelings are associated with motivation for activity and, in turn, sustained activity over time. Additionally, narrative storytelling is an effective method of persuading individuals to change their behavior. We propose that play of active video games that include compelling storylines will increase physical activity among a diverse sample of postmenopausal breast cancer survivors. To test this hypothesis, we will conduct a clinical trial that compares the enhanced intervention (story-based video games) to a standard intervention in 90 sedentary, overweight postmenopausal breast cancer survivors. Participants in the enhanced group will receive a mobile device and accessories with two story-based video game applications installed. The games incorporate behavior change strategies such as self-monitoring and feedback while also using game mechanics and a lengthy storyline to motivate physical activity. Participants in the standard group will receive the same mobile device with an electronic activity monitor and its companion feedback application. Both groups will receive brief weekly telephone counseling. By comparing two groups that both receive typical behavior change intervention components (counseling) and a novel electronic intervention, we will be able to investigate the specific effects of game mechanics and storytelling on motivation and physical activity. We will measure changes in physical activity, fitness, function, and quality of life from the beginning of the study to 6 months. We will also investigate further changes during an additional 6 month follow-up period in which participants keep their intervention tools but do not receive any counseling, to measure maintenance of activity. This project will develop and test a promising, innovative intervention that has the potential to be used on a widespread basis in clinical and community settings.


Recruitment information / eligibility

Status Completed
Enrollment 90
Est. completion date June 30, 2021
Est. primary completion date June 30, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 45 Years to 75 Years
Eligibility Inclusion Criteria: 1. Age between 45 and 75 years old 2. Report a breast cancer diagnosis no more than 10 years prior to enrollment 3. Cessation of menses for 12 months or more 4. Able to read and understand English 5. Able to read words in standard applications on a mobile device 3-4" large 6. Able to walk for exercise 7. Able to find transportation to the study location 8. Willing to use a mobile device provided by the study to participate (or to use one of their own) 9. Willing to be randomized to either group Exclusion Criteria: 1. Currently pregnant or nursing 2. Surgery in the past six months 3. Chemotherapy or radiation treatment in the past six months 4. Evidence of disease recurrence 5. Participant is active (90 minutes of moderate-vigorous intensity activity per week or more) 6. BMI is under 25 kg/m2 or over 35 kg/m2 7. Report a heart condition, chest pain during periods of activity or rest, loss of consciousness, etc. on the Physical Activity Readiness Questionnaire (PAR-Q), unless cleared by their physician 8. Participant reports hospitalization within the past year due to psychiatric problem(s) 9. Report current symptoms of alcohol or substance dependence 10. Plans to move away from the Galveston-Houston area or to be out of town for more than 1 week during the study period 11. Stroke, hip fracture, hip or knee replacement, or spinal surgery in the past 6 months 12. Report a history of severe orthopedic complications that would prevent optimal participation in the physical activities prescribed (e.g., severe arthritis, leg amputations, etc.) 13. Clinical judgment concerning safety 14. Lost more than 5% body weight in the previous 6 months 15. Currently participating in a physical activity or weight loss program 16. Current smoker 17. Participant already uses an electronic activity monitor (we will ask them to stop) 18. Another member of the household is a participant or staff member on this trial

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Game intervention
The game will target motivation via narrative and game mechanics. It will also encourage self-regulation by providing monitoring and feedback of activity. Counseling will be adapted to specifically reference concepts related to narrative and games.
Standard intervention
The electronic activity monitor will monitor steps, and the mobile device will provide basic feedback on progress toward goals. Counseling will be standard and concentrate on self-regulatory skill-building.

Locations

Country Name City State
United States The University of Texas Medical Branch Galveston Texas

Sponsors (2)

Lead Sponsor Collaborator
The University of Texas Medical Branch, Galveston American Cancer Society, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Maintenance of physical activity from 6 months to 1 year Minutes of moderate-vigorous physical activity measured over a 7 day period 6 months
Other Maintenance of physical fitness from 6 months to 1 year, measured by a 6 minute walk test We will use a 6 minute walk test to measure fitness 6 months
Other Maintenance of physical function from 6 months to 1 year, measured by the Senior Fitness Test We will use the Senior Fitness Test to measure physical function 6 months
Other Change in sleep from 6 months to 1 year, measured by a computerized PROMIS measure We will use a computerized PROMIS measure 6 months
Other Change in weight from 6 months to 1 year Weight will be measured using a calibrated scale 6 months
Other Adherence, measured by objective measures to investigate adherence to study protocols (game usage, monitor usage, phone calls completed, assessments attended, etc.) We will use objective measures to investigate adherence to study protocols (game usage, monitor usage, phone calls completed, assessments attended, etc.) 1 year
Other Number of participants who report adverse events We will inquire about potential adverse events during counseling calls and assessment visits. Discrete events will be summed, and the number of participants with events will be summed. 1 year
Other Change in anxiety from 6 months to 1 year, measured by a computerized PROMIS measure We will use a computerized PROMIS measure 6 months
Other Change in depression from 6 months to 1 year, measured by a computerized PROMIS measure We will use a computerized PROMIS measure specific to cancer patients/survivors 6 months
Other Change in fatigue from baseline to 6 months, measured by a computerized PROMIS measure We will use a computerized PROMIS measure specific to cancer patients/survivors 6 months
Other Change in quality of life from 6 months to 1 year as measured by Functional Assessment of Cancer Therapy - Breast measure We will use the Functional Assessment of Cancer Therapy - Breast measure 6 months
Other Change in motivation from 6 months to 1 year, measured by autonomous motivation specific to physical activity Behavioral Regulation in Exercise Questionnaire-2 will be used 6 months
Other Acceptability, measured using self-report measures of usability and liking of the apps Participants will report their perceptions of app usability and acceptability in the 6 month questionnaire 6 months
Other Play experience, measured using the play experience questionnaire Participants will self-report their perceptions of the playfulness of the intervention apps Measured at 3 months
Other Change in exercise identity from baseline to 6 months, measured using the Exercise Identity Scale We will use the Exercise Identity Scale 6 months
Other Narrative engagement (measured in narrative group only), measured using the Narrative Engagement Scale We will measure the extent to which participants in the narrative group felt narratively engaged in the game's storyline Measured at 3 months
Other Character identification (measured in narrative group only), measured using the Player Identification Scale We will measure the extent to which participants in the narrative group felt like they identified with their game character Measured at 3 months
Primary Change in physical activity from baseline to 6 month Minutes of moderate-vigorous physical activity over a 7 day period 6 months
Secondary Change in physical fitness from baseline to 6 months, as measured by 6 minute walk test We will use a 6 minute walk test to measure fitness 6 months
Secondary Change in physical function from baseline to 6 months as measured by the Senior Fitness Test We will use the Senior Fitness Test to measure physical function 6 months
Secondary Change in weight from baseline to 6 months We will measure weight using a calibrated scale 6 months
Secondary Change in quality of life from baseline to 6 months as measured by Functional Assessment of Cancer Therapy - Breast measure We will use the Functional Assessment of Cancer Therapy - Breast measure 6 months
Secondary Change in depression from baseline to 6 months, measured by a computerized PROMIS measure specific to cancer patients/survivors We will use a computerized PROMIS measure specific to cancer patients/survivors 6 months
Secondary Change in fatigue from baseline to 6 months, measured by a computerized PROMIS measure specific to cancer patients/survivors We will use a computerized PROMIS measure specific to cancer patients/survivors 6 months
Secondary Change in anxiety from baseline to 6 months, measured by a computerized PROMIS measure specific to cancer patients/survivors We will use a computerized PROMIS measure specific to cancer patients/survivors 6 months
Secondary Change in sleep from baseline to 6 months, measured by a computerized PROMIS measure We will use a computerized PROMIS measure 6 months
Secondary Change in motivation from baseline to 6 months, measured by autonomous motivation specific to physical activity Behavioral Regulation in Exercise Questionnaire-2 will be used 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A